Portunus trituberculatus isolate SZX2019 chromosome 13, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030083.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
myogenesis-regulating glycosidase-like, transcript variant X5
myogenesis-regulating glycosidase-like, transcript variant X3
myogenesis-regulating glycosidase-like, transcript variant X8
myogenesis-regulating glycosidase-like, transcript variant X4
myogenesis-regulating glycosidase-like, transcript variant X6
myogenesis-regulating glycosidase-like, transcript variant X7
myogenesis-regulating glycosidase-like, transcript variant X2
myogenesis-regulating glycosidase-like, transcript variant X1
myogenesis-regulating glycosidase-like, transcript variant X9
uncharacterized LOC123503178, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123503178, transcript variant X1
uncharacterized LOC123503178, transcript variant X2
uncharacterized LOC123503178, transcript variant X5
uncharacterized LOC123503178, transcript variant X6
uncharacterized protein LOC123503178 isoform X2
uncharacterized protein LOC123503178 isoform X1
uncharacterized LOC123503178, transcript variant X4
uncharacterized protein LOC123503178 isoform X4
uncharacterized protein LOC123503178 isoform X3
tumor necrosis factor alpha-induced protein 8-like protein
neural Wiskott-Aldrich syndrome protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sodium/hydrogen exchanger 9B2-like, transcript variant X1
sodium/hydrogen exchanger 9B2-like, transcript variant X4
sodium/hydrogen exchanger 9B2-like, transcript variant X2
sodium/hydrogen exchanger 9B2-like, transcript variant X3
sodium/hydrogen exchanger 9B2-like, transcript variant X10
sodium/hydrogen exchanger 9B2-like, transcript variant X9
sodium/hydrogen exchanger 9B2-like, transcript variant X6
sodium/hydrogen exchanger 9B2-like, transcript variant X8
sodium/hydrogen exchanger 9B2-like, transcript variant X5
sodium/hydrogen exchanger 9B2-like, transcript variant X7
sodium/hydrogen exchanger 9B2-like isoform X2
sodium/hydrogen exchanger 9B2-like isoform X1
sodium/hydrogen exchanger 9B2-like, transcript variant X11
sodium/hydrogen exchanger 9B2-like isoform X3
sodium/hydrogen exchanger 9B2-like isoform X4
serine/threonine-protein kinase SIK3-like, transcript variant X3
serine/threonine-protein kinase SIK2-like isoform X3
serine/threonine-protein kinase SIK3-like, transcript variant X1
serine/threonine-protein kinase SIK3-like, transcript variant X5
serine/threonine-protein kinase SIK3-like, transcript variant X2
serine/threonine-protein kinase SIK3-like, transcript variant X6
serine/threonine-protein kinase SIK2-like isoform X1
serine/threonine-protein kinase SIK3-like isoform X5
serine/threonine-protein kinase SIK2-like isoform X2
serine/threonine-protein kinase SIK3-like isoform X6
serine/threonine-protein kinase SIK3-like, transcript variant X4
serine/threonine-protein kinase SIK2-like isoform X4
cationic amino acid transporter 3-like, transcript variant X21
cationic amino acid transporter 3-like, transcript variant X20
cationic amino acid transporter 3-like, transcript variant X18
cationic amino acid transporter 3-like, transcript variant X16
cationic amino acid transporter 3-like, transcript variant X19
cationic amino acid transporter 3-like, transcript variant X17
cationic amino acid transporter 3-like isoform X4
cationic amino acid transporter 3-like, transcript variant X9
cationic amino acid transporter 3-like, transcript variant X4
cationic amino acid transporter 3-like, transcript variant X3
cationic amino acid transporter 3-like, transcript variant X14
cationic amino acid transporter 3-like, transcript variant X1
cationic amino acid transporter 3-like, transcript variant X2
cationic amino acid transporter 3-like, transcript variant X7
cationic amino acid transporter 3-like, transcript variant X5
cationic amino acid transporter 3-like, transcript variant X6
cationic amino acid transporter 3-like, transcript variant X13
cationic amino acid transporter 3-like, transcript variant X12
cationic amino acid transporter 3-like, transcript variant X10
cationic amino acid transporter 3-like, transcript variant X8
cationic amino acid transporter 3-like, transcript variant X11
cationic amino acid transporter 3-like, transcript variant X15
cationic amino acid transporter 3-like isoform X2
high affinity cationic amino acid transporter 1-like isoform X1
uncharacterized protein LOC123503032 isoform X3
uncharacterized LOC123503035, transcript variant X3
uncharacterized LOC123503035, transcript variant X2
uncharacterized protein LOC123503035 isoform X2
uncharacterized LOC123503035, transcript variant X1
uncharacterized protein LOC123503035 isoform X1
uncharacterized protein LOC123503035 isoform X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
vitelline membrane outer layer protein 1 homolog
uncharacterized LOC123503221, transcript variant X1
uncharacterized LOC123503221, transcript variant X2
uncharacterized protein LOC123503221 isoform X2
uncharacterized protein LOC123503221 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: venom carboxylesterase-6-like
secretory phospholipase A2 receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
serine/threonine-protein kinase tousled-like 2, transcript variant X3
serine/threonine-protein kinase tousled-like 2, transcript variant X2
serine/threonine-protein kinase tousled-like 2, transcript variant X11
serine/threonine-protein kinase tousled-like 2, transcript variant X6
serine/threonine-protein kinase tousled-like 2, transcript variant X13
serine/threonine-protein kinase tousled-like 2, transcript variant X10
serine/threonine-protein kinase tousled-like 2 isoform X4
serine/threonine-protein kinase tousled-like 2 isoform X11
serine/threonine-protein kinase tousled-like 2 isoform X8
serine/threonine-protein kinase tousled-like 2, transcript variant X1
serine/threonine-protein kinase tousled-like 2, transcript variant X7
serine/threonine-protein kinase tousled-like 2, transcript variant X14
serine/threonine-protein kinase tousled-like 2, transcript variant X4
serine/threonine-protein kinase tousled-like 2, transcript variant X9
serine/threonine-protein kinase tousled-like 2, transcript variant X5
serine/threonine-protein kinase tousled-like 2, transcript variant X12
serine/threonine-protein kinase tousled-like 2, transcript variant X8
serine/threonine-protein kinase tousled-like 2 isoform X3
serine/threonine-protein kinase tousled-like 2 isoform X10
serine/threonine-protein kinase tousled-like 2 isoform X6
serine/threonine-protein kinase tousled-like 2 isoform X9
serine/threonine-protein kinase tousled-like 2 isoform X1
serine/threonine-protein kinase tousled-like 2 isoform X5
serine/threonine-protein kinase tousled-like 2 isoform X2
serine/threonine-protein kinase tousled-like 2 isoform X7
serine/threonine-protein kinase tousled-like 2 isoform X12
uncharacterized LOC123503060, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123503060, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123503060, transcript variant X1
uncharacterized LOC123503060, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123503071, transcript variant X1
uncharacterized LOC123503071, transcript variant X2
uncharacterized LOC123503071, transcript variant X3
uncharacterized LOC123503071, transcript variant X4
uncharacterized protein LOC123503071 isoform X1
uncharacterized protein LOC123503071 isoform X2
putative inorganic phosphate cotransporter
AP-3 complex subunit sigma-1-like, transcript variant X2
AP-3 complex subunit sigma-2-like isoform X2
AP-3 complex subunit sigma-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
AP-3 complex subunit sigma-1-like, transcript variant X1
AP-3 complex subunit sigma-1-like isoform X1
AP-3 complex subunit sigma-2-like isoform X3
uncharacterized LOC123503074, transcript variant X8
lactosylceramide 4-alpha-galactosyltransferase-like
uncharacterized LOC123503074, transcript variant X6
uncharacterized LOC123503074, transcript variant X3
uncharacterized LOC123503074, transcript variant X4
uncharacterized LOC123503074, transcript variant X1
uncharacterized LOC123503074, transcript variant X7
uncharacterized LOC123503074, transcript variant X2
uncharacterized LOC123503074, transcript variant X5
N-acylneuraminate cytidylyltransferase A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeats and immunoglobulin-like domains protein 2, transcript variant X2
leucine-rich repeats and immunoglobulin-like domains protein 2, transcript variant X1
leucine-rich repeats and immunoglobulin-like domains protein 2, transcript variant X3
leucine-rich repeats and immunoglobulin-like domains protein 2
beta-mannosidase-like, transcript variant X4
beta-mannosidase-like, transcript variant X3
beta-mannosidase-like, transcript variant X2
beta-mannosidase-like, transcript variant X1
5'-nucleotidase domain-containing protein 3-like, transcript variant X2
5'-nucleotidase domain-containing protein 3-like, transcript variant X1
5'-nucleotidase domain-containing protein 3-like, transcript variant X4
5'-nucleotidase domain-containing protein 3-like, transcript variant X5
5'-nucleotidase domain-containing protein 3-like, transcript variant X7
5'-nucleotidase domain-containing protein 3-like, transcript variant X6
5'-nucleotidase domain-containing protein 3-like, transcript variant X8
5'-nucleotidase domain-containing protein 3-like, transcript variant X3
5'-nucleotidase domain-containing protein 3-like isoform X1
5'-nucleotidase domain-containing protein 3-like isoform X2
5'-nucleotidase domain-containing protein 3-like isoform X3
5'-nucleotidase domain-containing protein 3-like isoform X5
5'-nucleotidase domain-containing protein 3-like isoform X4
5'-nucleotidase domain-containing protein 3-like isoform X6
high affinity copper uptake protein 1-like, transcript variant X4
high affinity copper uptake protein 1-like, transcript variant X7
high affinity copper uptake protein 1-like, transcript variant X3
high affinity copper uptake protein 1-like, transcript variant X1
high affinity copper uptake protein 1-like, transcript variant X2
high affinity copper uptake protein 1-like isoform X1
high affinity copper uptake protein 1-like isoform X2
high affinity copper uptake protein 1-like, transcript variant X6
high affinity copper uptake protein 1-like, transcript variant X5
high affinity copper uptake protein 1-like isoform X3
transmembrane protein 222-like, transcript variant X5
transmembrane protein 222-like, transcript variant X6
transmembrane protein 222-like, transcript variant X4
transmembrane protein 222-like, transcript variant X3
transmembrane protein 222-like, transcript variant X2
transmembrane protein 222-like, transcript variant X1
transmembrane protein 222-like, transcript variant X8
transmembrane protein 222-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123503044, transcript variant X3
uncharacterized LOC123503044, transcript variant X1
uncharacterized LOC123503044, transcript variant X2
rapamycin-insensitive companion of mTOR-like
LOW QUALITY PROTEIN: rapamycin-insensitive companion of mTOR-like
mediator of RNA polymerase II transcription subunit 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: mediator of RNA polymerase II transcription subunit 1-like
ras-related protein Ral-a-like, transcript variant X1
ras-related protein Ral-a-like, transcript variant X2
ras-related protein Ral-a-like isoform X2
ras-related protein Ral-a-like isoform X1
dynein intermediate chain 2, ciliary-like, transcript variant X1
dynein intermediate chain 2, ciliary-like, transcript variant X4
dynein intermediate chain 2, ciliary-like, transcript variant X5
dynein intermediate chain 2, ciliary-like, transcript variant X2
dynein intermediate chain 2, ciliary-like, transcript variant X3
dynein intermediate chain 2, ciliary-like isoform X1
dynein intermediate chain 2, ciliary-like isoform X4
dynein intermediate chain 2, ciliary-like isoform X5
dynein intermediate chain 2, ciliary-like isoform X2
dynein intermediate chain 2, ciliary-like isoform X3
dynein intermediate chain 2, ciliary-like, transcript variant X6
dynein intermediate chain 2, ciliary-like isoform X6
dynein intermediate chain 2, ciliary-like, transcript variant X7
dynein intermediate chain 2, ciliary-like isoform X7
DNA-directed RNA polymerase II subunit RPB2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
similar to RNA sequence (same species):INSD:GFFJ01033937.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 202 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 142 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
cold and drought-regulated protein CORA-like
glycine-rich cell wall structural protein 1.0-like
putative polypeptide N-acetylgalactosaminyltransferase 9
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X4
arf-GAP with dual PH domain-containing protein 1-like isoform X3
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X2
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X3
arf-GAP with dual PH domain-containing protein 1-like, transcript variant X1
arf-GAP with dual PH domain-containing protein 1-like isoform X2
arf-GAP with dual PH domain-containing protein 1-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: COPII coat assembly protein sec16-like
E3 ubiquitin-protein ligase TTC3-like, transcript variant X8
E3 ubiquitin-protein ligase TTC3-like, transcript variant X6
E3 ubiquitin-protein ligase TTC3-like, transcript variant X2
uncharacterized protein LOC123503264 isoform X2
E3 ubiquitin-protein ligase TTC3-like isoform X6
E3 ubiquitin-protein ligase TTC3-like, transcript variant X5
E3 ubiquitin-protein ligase TTC3-like isoform X5
E3 ubiquitin-protein ligase TTC3-like, transcript variant X1
E3 ubiquitin-protein ligase TTC3-like, transcript variant X3
E3 ubiquitin-protein ligase TTC3-like, transcript variant X4
E3 ubiquitin-protein ligase TTC3-like, transcript variant X10
uncharacterized protein LOC123503264 isoform X1
uncharacterized protein LOC123503264 isoform X3
E3 ubiquitin-protein ligase TTC3-like isoform X4
E3 ubiquitin-protein ligase TTC3-like isoform X8
E3 ubiquitin-protein ligase TTC3-like, transcript variant X7
E3 ubiquitin-protein ligase TTC3-like, transcript variant X9
E3 ubiquitin-protein ligase TTC3-like isoform X7
pollen-specific leucine-rich repeat extensin-like protein 1, transcript variant X3
pollen-specific leucine-rich repeat extensin-like protein 1, transcript variant X1
pollen-specific leucine-rich repeat extensin-like protein 1, transcript variant X2
pollen-specific leucine-rich repeat extensin-like protein 1
facilitated trehalose transporter Tret1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: facilitated trehalose transporter Tret1-like
ubiquitin carboxyl-terminal hydrolase 31-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 31-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 31-like isoform X1
ubiquitin carboxyl-terminal hydrolase 31-like isoform X2
IDLSRF-like peptide, transcript variant X2
IDLSRF-like peptide, transcript variant X1
IDLSRF-like peptide, transcript variant X4
IDLSRF-like peptide, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X1
trimethyllysine dioxygenase, mitochondrial-like, transcript variant X2
trimethyllysine dioxygenase, mitochondrial-like isoform X1
trimethyllysine dioxygenase, mitochondrial-like isoform X2
protein aveugle-like, transcript variant X1
protein aveugle-like, transcript variant X3
protein aveugle-like, transcript variant X2
chymotrypsin-like elastase family member 3B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
irregular chiasm C-roughest protein-like, transcript variant X4
irregular chiasm C-roughest protein-like, transcript variant X3
irregular chiasm C-roughest protein-like, transcript variant X1
irregular chiasm C-roughest protein-like, transcript variant X7
irregular chiasm C-roughest protein-like, transcript variant X2
irregular chiasm C-roughest protein-like, transcript variant X5
irregular chiasm C-roughest protein-like, transcript variant X6
irregular chiasm C-roughest protein-like isoform X1
irregular chiasm C-roughest protein-like isoform X2
LOW QUALITY PROTEIN: dopamine receptor 1-like
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
muscle calcium channel subunit alpha-1-like, transcript variant X44
muscle calcium channel subunit alpha-1-like, transcript variant X47
muscle calcium channel subunit alpha-1-like, transcript variant X11
muscle calcium channel subunit alpha-1-like, transcript variant X9
muscle calcium channel subunit alpha-1-like, transcript variant X2
muscle calcium channel subunit alpha-1-like, transcript variant X21
muscle calcium channel subunit alpha-1-like, transcript variant X12
muscle calcium channel subunit alpha-1-like, transcript variant X10
muscle calcium channel subunit alpha-1-like, transcript variant X19
muscle calcium channel subunit alpha-1-like, transcript variant X5
muscle calcium channel subunit alpha-1-like, transcript variant X16
muscle calcium channel subunit alpha-1-like, transcript variant X15
muscle calcium channel subunit alpha-1-like, transcript variant X1
muscle calcium channel subunit alpha-1-like, transcript variant X23
muscle calcium channel subunit alpha-1-like, transcript variant X27
muscle calcium channel subunit alpha-1-like, transcript variant X18
muscle calcium channel subunit alpha-1-like, transcript variant X34
muscle calcium channel subunit alpha-1-like, transcript variant X22
muscle calcium channel subunit alpha-1-like, transcript variant X26
muscle calcium channel subunit alpha-1-like, transcript variant X14
muscle calcium channel subunit alpha-1-like, transcript variant X13
muscle calcium channel subunit alpha-1-like, transcript variant X8
muscle calcium channel subunit alpha-1-like, transcript variant X6
muscle calcium channel subunit alpha-1-like, transcript variant X4
muscle calcium channel subunit alpha-1-like, transcript variant X7
muscle calcium channel subunit alpha-1-like, transcript variant X17
muscle calcium channel subunit alpha-1-like, transcript variant X24
muscle calcium channel subunit alpha-1-like, transcript variant X3
muscle calcium channel subunit alpha-1-like, transcript variant X25
muscle calcium channel subunit alpha-1-like, transcript variant X30
muscle calcium channel subunit alpha-1-like, transcript variant X38
muscle calcium channel subunit alpha-1-like, transcript variant X20
muscle calcium channel subunit alpha-1-like, transcript variant X28
muscle calcium channel subunit alpha-1-like, transcript variant X36
muscle calcium channel subunit alpha-1-like, transcript variant X29
muscle calcium channel subunit alpha-1-like, transcript variant X41
muscle calcium channel subunit alpha-1-like, transcript variant X42
muscle calcium channel subunit alpha-1-like isoform X3
muscle calcium channel subunit alpha-1-like isoform X25
muscle calcium channel subunit alpha-1-like isoform X29
muscle calcium channel subunit alpha-1-like isoform X30
muscle calcium channel subunit alpha-1-like isoform X11
muscle calcium channel subunit alpha-1-like isoform X5
muscle calcium channel subunit alpha-1-like isoform X16
muscle calcium channel subunit alpha-1-like isoform X15
muscle calcium channel subunit alpha-1-like isoform X9
muscle calcium channel subunit alpha-1-like isoform X2
muscle calcium channel subunit alpha-1-like isoform X21
muscle calcium channel subunit alpha-1-like isoform X36
muscle calcium channel subunit alpha-1-like isoform X1
muscle calcium channel subunit alpha-1-like isoform X39
muscle calcium channel subunit alpha-1-like isoform X23
muscle calcium channel subunit alpha-1-like isoform X12
muscle calcium channel subunit alpha-1-like isoform X40
muscle calcium channel subunit alpha-1-like isoform X27
muscle calcium channel subunit alpha-1-like isoform X18
muscle calcium channel subunit alpha-1-like isoform X32
muscle calcium channel subunit alpha-1-like isoform X22
muscle calcium channel subunit alpha-1-like isoform X26
muscle calcium channel subunit alpha-1-like isoform X20
muscle calcium channel subunit alpha-1-like isoform X14
muscle calcium channel subunit alpha-1-like isoform X13
muscle calcium channel subunit alpha-1-like isoform X8
muscle calcium channel subunit alpha-1-like isoform X10
muscle calcium channel subunit alpha-1-like isoform X6
muscle calcium channel subunit alpha-1-like isoform X4
muscle calcium channel subunit alpha-1-like isoform X7
muscle calcium channel subunit alpha-1-like isoform X17
muscle calcium channel subunit alpha-1-like isoform X24
muscle calcium channel subunit alpha-1-like isoform X28
muscle calcium channel subunit alpha-1-like isoform X34
muscle calcium channel subunit alpha-1-like isoform X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
muscle calcium channel subunit alpha-1-like, transcript variant X31
muscle calcium channel subunit alpha-1-like, transcript variant X37
muscle calcium channel subunit alpha-1-like, transcript variant X32
muscle calcium channel subunit alpha-1-like, transcript variant X33
muscle calcium channel subunit alpha-1-like isoform X31
muscle calcium channel subunit alpha-1-like isoform X35
muscle calcium channel subunit alpha-1-like, transcript variant X49
muscle calcium channel subunit alpha-1-like, transcript variant X43
muscle calcium channel subunit alpha-1-like, transcript variant X40
muscle calcium channel subunit alpha-1-like isoform X38
muscle calcium channel subunit alpha-1-like isoform X41
muscle calcium channel subunit alpha-1-like, transcript variant X46
muscle calcium channel subunit alpha-1-like, transcript variant X48
muscle calcium channel subunit alpha-1-like, transcript variant X45
muscle calcium channel subunit alpha-1-like, transcript variant X50
muscle calcium channel subunit alpha-1-like, transcript variant X39
muscle calcium channel subunit alpha-1-like, transcript variant X35
muscle calcium channel subunit alpha-1-like isoform X33
muscle calcium channel subunit alpha-1-like isoform X37
muscle calcium channel subunit alpha-1-like isoform X42
muscle calcium channel subunit alpha-1-like isoform X43
transmembrane protein KIAA1109-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein KIAA1109-like, transcript variant X1
transmembrane protein KIAA1109-like, transcript variant X8
transmembrane protein KIAA1109-like, transcript variant X14
transmembrane protein KIAA1109-like, transcript variant X12
transmembrane protein KIAA1109-like, transcript variant X15
transmembrane protein KIAA1109-like, transcript variant X11
transmembrane protein KIAA1109-like, transcript variant X4
transmembrane protein KIAA1109-like, transcript variant X19
transmembrane protein KIAA1109-like, transcript variant X9
transmembrane protein KIAA1109-like, transcript variant X7
transmembrane protein KIAA1109-like, transcript variant X10
transmembrane protein KIAA1109-like, transcript variant X13
transmembrane protein KIAA1109-like, transcript variant X2
transmembrane protein KIAA1109-like, transcript variant X17
transmembrane protein KIAA1109-like, transcript variant X5
transmembrane protein KIAA1109-like, transcript variant X6
transmembrane protein KIAA1109-like, transcript variant X18
transmembrane protein KIAA1109-like, transcript variant X3
transmembrane protein KIAA1109-like isoform X1
transmembrane protein KIAA1109-like isoform X8
transmembrane protein KIAA1109-like isoform X14
transmembrane protein KIAA1109-like isoform X12
transmembrane protein KIAA1109-like isoform X15
transmembrane protein KIAA1109-like isoform X11
transmembrane protein KIAA1109-like isoform X4
transmembrane protein KIAA1109-like isoform X19
transmembrane protein KIAA1109-like isoform X9
transmembrane protein KIAA1109-like isoform X7
transmembrane protein KIAA1109-like isoform X10
transmembrane protein KIAA1109-like isoform X13
transmembrane protein KIAA1109-like isoform X2
transmembrane protein KIAA1109-like isoform X17
transmembrane protein KIAA1109-like isoform X5
transmembrane protein KIAA1109-like isoform X6
transmembrane protein KIAA1109-like isoform X18
transmembrane protein KIAA1109-like isoform X3
transmembrane protein KIAA1109-like isoform X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chondramide synthase cmdD-like, transcript variant X2
chondramide synthase cmdD-like, transcript variant X5
chondramide synthase cmdD-like, transcript variant X4
chondramide synthase cmdD-like, transcript variant X1
chondramide synthase cmdD-like, transcript variant X3
chondramide synthase cmdD-like, transcript variant X7
chondramide synthase cmdD-like, transcript variant X6
chondramide synthase cmdD-like isoform X3
mycosubtilin synthase subunit C-like isoform X1
chondramide synthase cmdD-like isoform X4
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
osmotic avoidance abnormal protein 3-like, transcript variant X4
osmotic avoidance abnormal protein 3-like, transcript variant X1
osmotic avoidance abnormal protein 3-like, transcript variant X3
osmotic avoidance abnormal protein 3-like, transcript variant X2
osmotic avoidance abnormal protein 3-like isoform X4
osmotic avoidance abnormal protein 3-like isoform X1
osmotic avoidance abnormal protein 3-like isoform X3
osmotic avoidance abnormal protein 3-like isoform X2
tigger transposable element-derived protein 2-like, transcript variant X5
tigger transposable element-derived protein 2-like, transcript variant X4
tigger transposable element-derived protein 2-like, transcript variant X3
tigger transposable element-derived protein 2-like, transcript variant X1
tigger transposable element-derived protein 2-like, transcript variant X2
tigger transposable element-derived protein 2-like, transcript variant X6
uncharacterized protein LOC123503156 isoform X1
tigger transposable element-derived protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503108
uncharacterized protein DDB_G0290685-like
zinc finger protein 345-like, transcript variant X2
zinc finger protein 345-like, transcript variant X1
uncharacterized LOC123502935, transcript variant X4
uncharacterized LOC123502935, transcript variant X1
uncharacterized LOC123502935, transcript variant X2
uncharacterized LOC123502935, transcript variant X3
uncharacterized protein LOC123502935 isoform X1
uncharacterized protein LOC123502935 isoform X2
uncharacterized protein LOC123502935 isoform X3
proline-rich receptor-like protein kinase PERK2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
kinesin heavy chain-like, transcript variant X5
kinesin heavy chain-like, transcript variant X2
kinesin heavy chain-like, transcript variant X1
kinesin heavy chain-like, transcript variant X3
kinesin heavy chain-like, transcript variant X4
putative gamma-glutamylcyclotransferase CG2811, transcript variant X3
putative gamma-glutamylcyclotransferase CG2811, transcript variant X1
putative gamma-glutamylcyclotransferase CG2811, transcript variant X4
putative gamma-glutamylcyclotransferase CG2811, transcript variant X2
putative gamma-glutamylcyclotransferase CG2811 isoform X2
putative gamma-glutamylcyclotransferase CG2811 isoform X1
baculoviral IAP repeat-containing protein 7-like, transcript variant X2
baculoviral IAP repeat-containing protein 7-like, transcript variant X1
baculoviral IAP repeat-containing protein 7-like
acyl-coenzyme A diphosphatase FITM2-like, transcript variant X2
acyl-coenzyme A diphosphatase FITM2-like, transcript variant X1
acyl-coenzyme A diphosphatase FITM2-like, transcript variant X3
acyl-coenzyme A diphosphatase FITM2-like isoform X1
acyl-coenzyme A diphosphatase FITM2-like isoform X2
acyl-coenzyme A diphosphatase FITM2-like isoform X3
guanine nucleotide-binding protein-like 1, transcript variant X2
guanine nucleotide-binding protein-like 1, transcript variant X1
guanine nucleotide-binding protein-like 1, transcript variant X3
guanine nucleotide-binding protein-like 1 isoform X1
guanine nucleotide-binding protein-like 1, transcript variant X4
guanine nucleotide-binding protein-like 1 isoform X2
actin-2, muscle-specific-like, transcript variant X2
actin-2, muscle-specific-like, transcript variant X3
actin-2, muscle-specific-like, transcript variant X1
actin-2, muscle-specific-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 884 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
actin, muscle-like, transcript variant X1
actin, muscle-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 234 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 234 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
NADPH-dependent diflavin oxidoreductase 1-like
vesicle-trafficking protein SEC22b-B-like
actin-related protein 2/3 complex subunit 4, transcript variant X2
actin-related protein 2/3 complex subunit 4, transcript variant X1
actin-related protein 2/3 complex subunit 4 isoform X2
actin-related protein 2/3 complex subunit 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like, transcript variant X2
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ATP-dependent DNA helicase DDX11-like, transcript variant X1
ATP-dependent DNA helicase DDX11-like, transcript variant X2
uncharacterized LOC123503286, transcript variant X4
uncharacterized LOC123503286, transcript variant X5
uncharacterized LOC123503286, transcript variant X2
uncharacterized LOC123503286, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503286, transcript variant X6
uncharacterized LOC123503286, transcript variant X1
uncharacterized LOC123503286, transcript variant X7
uncharacterized protein LOC123503286 isoform X1
uncharacterized protein LOC123503286 isoform X2
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X4
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X1
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X3
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X2
26S proteasome non-ATPase regulatory subunit 10-like
phosphoribosyl pyrophosphate synthase-associated protein 1-like, transcript variant X3
phosphoribosyl pyrophosphate synthase-associated protein 1-like, transcript variant X1
phosphoribosyl pyrophosphate synthase-associated protein 1-like, transcript variant X4
phosphoribosyl pyrophosphate synthase-associated protein 1-like, transcript variant X2
phosphoribosyl pyrophosphate synthase-associated protein 1-like, transcript variant X5
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X3
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X1
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X4
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X2
phosphoribosyl pyrophosphate synthase-associated protein 1-like isoform X5
protein suppressor of forked-like, transcript variant X1
protein suppressor of forked-like, transcript variant X2
protein suppressor of forked-like isoform X1
protein suppressor of forked-like isoform X2
serine/arginine-rich splicing factor 7-like, transcript variant X2
serine/arginine-rich splicing factor 7-like, transcript variant X3
serine/arginine-rich splicing factor 7-like, transcript variant X7
serine/arginine-rich splicing factor 7-like, transcript variant X5
serine/arginine-rich splicing factor 7-like, transcript variant X4
serine/arginine-rich splicing factor 7-like, transcript variant X9
serine/arginine-rich splicing factor 7-like, transcript variant X8
serine/arginine-rich splicing factor 7-like, transcript variant X6
serine/arginine-rich splicing factor 7-like, transcript variant X13
serine/arginine-rich splicing factor 7-like, transcript variant X15
serine/arginine-rich splicing factor 7-like, transcript variant X17
serine/arginine-rich splicing factor 7-like, transcript variant X1
serine/arginine-rich splicing factor 7-like, transcript variant X14
serine/arginine-rich splicing factor 7-like, transcript variant X16
serine/arginine-rich splicing factor 7-like, transcript variant X12
serine/arginine-rich splicing factor 7-like, transcript variant X10
serine/arginine-rich splicing factor 7-like, transcript variant X11
arginine/serine-rich coiled-coil protein 2-like isoform X1
serine/arginine-rich splicing factor 7-like isoform X3
arginine/serine-rich coiled-coil protein 2-like isoform X2
sequestosome-1-like, transcript variant X2
sequestosome-1-like, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 1-like isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cysteine-rich hydrophobic domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
cysteine-rich hydrophobic domain-containing protein 2-like, transcript variant X2
cysteine-rich hydrophobic domain-containing protein 2-like, transcript variant X1
cysteine-rich hydrophobic domain-containing protein 2-like isoform X1
cysteine-rich hydrophobic domain-containing protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cysteine-rich hydrophobic domain-containing protein 2-like isoform X2
uncharacterized LOC123503299, transcript variant X1
uncharacterized LOC123503299, transcript variant X2
uncharacterized protein LOC123503299 isoform X2
uncharacterized protein LOC123503299 isoform X1
tigger transposable element-derived protein 4-like, transcript variant X1
tigger transposable element-derived protein 4-like, transcript variant X3
tigger transposable element-derived protein 4-like, transcript variant X2
tigger transposable element-derived protein 4-like
tigger transposable element-derived protein 4-like isoform X1
tigger transposable element-derived protein 4-like isoform X2
tigger transposable element-derived protein 4-like isoform X3
solute carrier family 25 member 45-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 25 member 45-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 25 member 45-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 25 member 45-like isoform X1
solute carrier family 25 member 45-like isoform X2
solute carrier family 25 member 45-like isoform X3
EGF-like repeat and discoidin I-like domain-containing protein 3
disintegrin and metalloproteinase domain-containing protein 10-like
uncharacterized LOC123503250, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503250, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LOW QUALITY PROTEIN: aminopeptidase Ey-like
alpha-(1,3)-fucosyltransferase C-like, transcript variant X3
alpha-(1,3)-fucosyltransferase C-like, transcript variant X1
alpha-(1,3)-fucosyltransferase C-like, transcript variant X4
alpha-(1,3)-fucosyltransferase C-like, transcript variant X2
alpha-(1,3)-fucosyltransferase C-like, transcript variant X5
alpha-(1,3)-fucosyltransferase C-like isoform X1
alpha-(1,3)-fucosyltransferase C-like isoform X2
uncharacterized LOC123503140, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123503140, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC123503095, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123503095, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123503095, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
discoidin domain-containing receptor tyrosine kinase B-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
LOW QUALITY PROTEIN: seminal metalloprotease 1-like
protein quiver-like, transcript variant X2
protein quiver-like, transcript variant X1
protein quiver-like, transcript variant X3
protein quiver-like, transcript variant X4
protein quiver-like, transcript variant X6
protein quiver-like, transcript variant X5
protein quiver-like, transcript variant X7
protein quiver-like, transcript variant X8
uncharacterized LOC123502981, transcript variant X2
uncharacterized LOC123502981, transcript variant X5
uncharacterized LOC123502981, transcript variant X4
uncharacterized LOC123502981, transcript variant X3
uncharacterized LOC123502981, transcript variant X1
uncharacterized protein LOC123502981 isoform X1
uncharacterized protein LOC123502981 isoform X3
uncharacterized protein LOC123502981 isoform X2
cyclic AMP-dependent transcription factor ATF-2-like, transcript variant X1
cyclic AMP-dependent transcription factor ATF-2-like, transcript variant X4
cyclic AMP-dependent transcription factor ATF-2-like, transcript variant X3
cyclic AMP-dependent transcription factor ATF-2-like, transcript variant X2
cyclic AMP-dependent transcription factor ATF-2-like isoform X1
cyclic AMP-dependent transcription factor ATF-2-like isoform X3
cyclic AMP-dependent transcription factor ATF-2-like isoform X2
rRNA methyltransferase 3, mitochondrial-like, transcript variant X2
rRNA methyltransferase 3, mitochondrial-like, transcript variant X3
rRNA methyltransferase 3, mitochondrial-like, transcript variant X1
rRNA methyltransferase 3, mitochondrial-like, transcript variant X5
rRNA methyltransferase 3, mitochondrial-like, transcript variant X4
rRNA methyltransferase 3, mitochondrial-like isoform X2
rRNA methyltransferase 3, mitochondrial-like isoform X1
4-coumarate--CoA ligase 4-like, transcript variant X2
4-coumarate--CoA ligase 4-like, transcript variant X1
4-coumarate--CoA ligase 4-like isoform X2
inositol polyphosphate-4-phosphatase type I A-like
LOW QUALITY PROTEIN: inositol polyphosphate-4-phosphatase type I A-like
ubiquitin carboxyl-terminal hydrolase isozyme L3-like
uncharacterized LOC123503042, transcript variant X3
uncharacterized LOC123503042, transcript variant X4
uncharacterized LOC123503042, transcript variant X1
uncharacterized LOC123503042, transcript variant X2
DNA-directed primase/polymerase protein-like, transcript variant X2
DNA-directed primase/polymerase protein-like, transcript variant X1
DNA-directed primase/polymerase protein-like
transfer RNA valine (anticodon GAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
5-hydroxytryptamine receptor 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
5-hydroxytryptamine receptor 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
5-hydroxytryptamine receptor 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
5-hydroxytryptamine receptor 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
discoidin domain-containing receptor 2-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: discoidin domain-containing receptor 2-like
protein TRACHEARY ELEMENT DIFFERENTIATION-RELATED 7A-like
cytochrome c oxidase subunit 6B2-like, transcript variant X1
cytochrome c oxidase subunit 6B2-like, transcript variant X2
cytochrome c oxidase subunit 6B2-like, transcript variant X3
cytochrome c oxidase subunit 6B2-like isoform X1
cytochrome c oxidase subunit 6B2-like isoform X2
insulin-like growth factor-binding protein complex acid labile subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: insulin-like growth factor-binding protein complex acid labile subunit
PDZ domain-containing protein GIPC3-like
extracellular signal-regulated kinase 2-like, transcript variant X1
extracellular signal-regulated kinase 2-like isoform X1
extracellular signal-regulated kinase 2-like, transcript variant X2
mitogen-activated protein kinase 15-like isoform X2
uncharacterized LOC123503194, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123503194, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytoplasmic dynein 1 intermediate chain-like, transcript variant X8
cytoplasmic dynein 1 intermediate chain-like, transcript variant X27
cytoplasmic dynein 1 intermediate chain-like, transcript variant X32
cytoplasmic dynein 1 intermediate chain-like, transcript variant X38
cytoplasmic dynein 1 intermediate chain-like, transcript variant X41
cytoplasmic dynein 1 intermediate chain-like, transcript variant X40
cytoplasmic dynein 1 intermediate chain-like, transcript variant X39
cytoplasmic dynein 1 intermediate chain-like, transcript variant X35
cytoplasmic dynein 1 intermediate chain-like, transcript variant X31
cytoplasmic dynein 1 intermediate chain-like, transcript variant X28
cytoplasmic dynein 1 intermediate chain-like, transcript variant X29
cytoplasmic dynein 1 intermediate chain-like, transcript variant X20
cytoplasmic dynein 1 intermediate chain-like, transcript variant X13
cytoplasmic dynein 1 intermediate chain-like, transcript variant X37
cytoplasmic dynein 1 intermediate chain-like, transcript variant X36
cytoplasmic dynein 1 intermediate chain-like, transcript variant X34
cytoplasmic dynein 1 intermediate chain-like, transcript variant X30
cytoplasmic dynein 1 intermediate chain-like, transcript variant X24
cytoplasmic dynein 1 intermediate chain-like, transcript variant X21
cytoplasmic dynein 1 intermediate chain-like, transcript variant X22
cytoplasmic dynein 1 intermediate chain-like, transcript variant X15
cytoplasmic dynein 1 intermediate chain-like, transcript variant X6
cytoplasmic dynein 1 intermediate chain-like, transcript variant X17
cytoplasmic dynein 1 intermediate chain-like, transcript variant X26
cytoplasmic dynein 1 intermediate chain-like, transcript variant X19
cytoplasmic dynein 1 intermediate chain-like, transcript variant X16
cytoplasmic dynein 1 intermediate chain-like, transcript variant X9
cytoplasmic dynein 1 intermediate chain-like, transcript variant X12
cytoplasmic dynein 1 intermediate chain-like, transcript variant X5
cytoplasmic dynein 1 intermediate chain-like, transcript variant X2
cytoplasmic dynein 1 intermediate chain-like, transcript variant X33
cytoplasmic dynein 1 intermediate chain-like, transcript variant X25
cytoplasmic dynein 1 intermediate chain-like, transcript variant X23
cytoplasmic dynein 1 intermediate chain-like, transcript variant X18
cytoplasmic dynein 1 intermediate chain-like, transcript variant X10
cytoplasmic dynein 1 intermediate chain-like, transcript variant X11
cytoplasmic dynein 1 intermediate chain-like, transcript variant X7
cytoplasmic dynein 1 intermediate chain-like, transcript variant X4
cytoplasmic dynein 1 intermediate chain-like, transcript variant X3
cytoplasmic dynein 1 intermediate chain-like, transcript variant X1
cytoplasmic dynein 1 intermediate chain-like, transcript variant X14
cytoplasmic dynein 1 intermediate chain 2-like isoform X37
cytoplasmic dynein 1 intermediate chain-like isoform X26
cytoplasmic dynein 1 intermediate chain 2-like isoform X39
cytoplasmic dynein 1 intermediate chain-like isoform X40
cytoplasmic dynein 1 intermediate chain 2-like isoform X31
cytoplasmic dynein 1 intermediate chain-like isoform X8
cytoplasmic dynein 1 intermediate chain 2-like isoform X38
cytoplasmic dynein 1 intermediate chain 2-like isoform X34
cytoplasmic dynein 1 intermediate chain 2-like isoform X30
cytoplasmic dynein 1 intermediate chain 2-like isoform X27
cytoplasmic dynein 1 intermediate chain 2-like isoform X28
cytoplasmic dynein 1 intermediate chain 2-like isoform X19
cytoplasmic dynein 1 intermediate chain-like isoform X13
cytoplasmic dynein 1 intermediate chain 2-like isoform X36
cytoplasmic dynein 1 intermediate chain 2-like isoform X35
cytoplasmic dynein 1 intermediate chain 2-like isoform X33
cytoplasmic dynein 1 intermediate chain 2-like isoform X29
cytoplasmic dynein 1 intermediate chain-like isoform X23
cytoplasmic dynein 1 intermediate chain-like isoform X20
cytoplasmic dynein 1 intermediate chain 2-like isoform X21
cytoplasmic dynein 1 intermediate chain 2-like isoform X14
cytoplasmic dynein 1 intermediate chain-like isoform X6
cytoplasmic dynein 1 intermediate chain-like isoform X16
cytoplasmic dynein 1 intermediate chain-like isoform X25
cytoplasmic dynein 1 intermediate chain-like isoform X18
cytoplasmic dynein 1 intermediate chain-like isoform X15
cytoplasmic dynein 1 intermediate chain-like isoform X9
cytoplasmic dynein 1 intermediate chain-like isoform X12
cytoplasmic dynein 1 intermediate chain-like isoform X5
cytoplasmic dynein 1 intermediate chain-like isoform X2
cytoplasmic dynein 1 intermediate chain 2-like isoform X32
cytoplasmic dynein 1 intermediate chain 2-like isoform X24
cytoplasmic dynein 1 intermediate chain 2-like isoform X22
cytoplasmic dynein 1 intermediate chain 2-like isoform X17
cytoplasmic dynein 1 intermediate chain-like isoform X10
cytoplasmic dynein 1 intermediate chain 2-like isoform X11
cytoplasmic dynein 1 intermediate chain 2-like isoform X7
cytoplasmic dynein 1 intermediate chain 2-like isoform X4
cytoplasmic dynein 1 intermediate chain-like isoform X3
cytoplasmic dynein 1 intermediate chain-like isoform X1
regulator of G-protein signaling 9-binding protein-like
serine/threonine-protein phosphatase PGAM5, mitochondrial-like, transcript variant X2
serine/threonine-protein phosphatase PGAM5, mitochondrial-like, transcript variant X1
serine/threonine-protein phosphatase PGAM5, mitochondrial-like, transcript variant X3
serine/threonine-protein phosphatase PGAM5, mitochondrial-like isoform X1
serine/threonine-protein phosphatase PGAM5, mitochondrial-like isoform X2
uncharacterized LOC123503007, transcript variant X2
uncharacterized LOC123503007, transcript variant X1
uncharacterized LOC123503007, transcript variant X3
uncharacterized protein LOC123503007 isoform X1
uncharacterized protein LOC123503007 isoform X2
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X4
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X5
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X3
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X6
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X7
tyrosine-protein phosphatase non-receptor type 4-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type 4-like isoform X2
tyrosine-protein phosphatase non-receptor type 4-like isoform X4
tyrosine-protein phosphatase non-receptor type 4-like isoform X5
tyrosine-protein phosphatase non-receptor type 4-like isoform X1
tyrosine-protein phosphatase non-receptor type 4-like isoform X3
RNA-binding protein with serine-rich domain 1-like
cyclin-G-associated kinase-like, transcript variant X6
cyclin-G-associated kinase-like, transcript variant X7
cyclin-G-associated kinase-like, transcript variant X5
cyclin-G-associated kinase-like, transcript variant X3
cyclin-G-associated kinase-like, transcript variant X4
cyclin-G-associated kinase-like, transcript variant X2
cyclin-G-associated kinase-like, transcript variant X1
cyclin-G-associated kinase-like isoform X2
cyclin-G-associated kinase-like isoform X3
cyclin-G-associated kinase-like isoform X1
U5 small nuclear ribonucleoprotein 40 kDa protein-like, transcript variant X2
U5 small nuclear ribonucleoprotein 40 kDa protein-like, transcript variant X1
U5 small nuclear ribonucleoprotein 40 kDa protein-like isoform X1
U5 small nuclear ribonucleoprotein 40 kDa protein-like isoform X2
sphingomyelin phosphodiesterase 4-like, transcript variant X2
sphingomyelin phosphodiesterase 4-like, transcript variant X3
sphingomyelin phosphodiesterase 4-like, transcript variant X1
sphingomyelin phosphodiesterase 4-like isoform X2
sphingomyelin phosphodiesterase 4-like isoform X3
sphingomyelin phosphodiesterase 4-like isoform X1
rap guanine nucleotide exchange factor 4-like, transcript variant X2
rap guanine nucleotide exchange factor 4-like, transcript variant X1
rap guanine nucleotide exchange factor 4-like, transcript variant X3
rap guanine nucleotide exchange factor 4-like, transcript variant X5
rap guanine nucleotide exchange factor 4-like, transcript variant X4
rap guanine nucleotide exchange factor 4-like, transcript variant X8
rap guanine nucleotide exchange factor 4-like, transcript variant X10
rap guanine nucleotide exchange factor 4-like, transcript variant X7
rap guanine nucleotide exchange factor 4-like, transcript variant X9
rap guanine nucleotide exchange factor 4-like, transcript variant X6
rap guanine nucleotide exchange factor 4-like, transcript variant X11
rap guanine nucleotide exchange factor 4-like isoform X2
rap guanine nucleotide exchange factor 4-like isoform X1
rap guanine nucleotide exchange factor 4-like isoform X3
rap guanine nucleotide exchange factor 4-like isoform X5
rap guanine nucleotide exchange factor 4-like isoform X4
rap guanine nucleotide exchange factor 4-like isoform X6
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123503087, transcript variant X2
uncharacterized LOC123503087, transcript variant X3
uncharacterized LOC123503087, transcript variant X1
uncharacterized LOC123503087, transcript variant X4
uncharacterized LOC123503087, transcript variant X5
uncharacterized protein LOC123503087 isoform X4
uncharacterized protein LOC123503087 isoform X2
uncharacterized protein LOC123503087 isoform X3
uncharacterized protein LOC123503087 isoform X1
uncharacterized LOC123503087, transcript variant X6
uncharacterized protein LOC123503087 isoform X5
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X1
calcium/calmodulin-dependent protein kinase type IV-like isoform X1
calcium/calmodulin-dependent protein kinase type IV-like, transcript variant X2
calcium/calmodulin-dependent protein kinase type IV-like isoform X2
uncharacterized LOC123503090, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123503090, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123503090, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC123503090, transcript variant X4
uncharacterized LOC123503090, transcript variant X5
uncharacterized LOC123503090, transcript variant X6
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LIM/homeobox protein Lhx1-like, transcript variant X1
LIM/homeobox protein Lhx1-like, transcript variant X2
LIM/homeobox protein Lhx1-like isoform X1
LIM/homeobox protein Lhx1-like isoform X2
uncharacterized LOC123503099, transcript variant X2
uncharacterized LOC123503099, transcript variant X1
LIM/homeobox protein Lhx1-like, transcript variant X3
LIM/homeobox protein Lhx1-like isoform X3
transmembrane 9 superfamily member 2-like
phenylalanine--tRNA ligase beta subunit-like
guanine nucleotide-binding protein subunit alpha-14-like
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X3
N-acetylneuraminate 9-O-acetyltransferase-like isoform X1
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
N-acetylneuraminate 9-O-acetyltransferase-like isoform X2
N-acetylneuraminate 9-O-acetyltransferase-like isoform X3
uncharacterized LOC123503039, transcript variant X2
uncharacterized LOC123503039, transcript variant X1
uncharacterized LOC123503218, transcript variant X2
uncharacterized LOC123503218, transcript variant X1
DNA helicase MCM8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA helicase MCM8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA helicase MCM8-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DNA helicase MCM8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA helicase MCM8-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
DNA helicase MCM8-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
G-protein coupled receptor Mth2-like, transcript variant X4
G-protein coupled receptor Mth2-like, transcript variant X3
G-protein coupled receptor Mth2-like, transcript variant X5
G-protein coupled receptor Mth2-like isoform X3
uncharacterized protein LOC123503143 isoform X2
G-protein coupled receptor Mth2-like isoform X4
G-protein coupled receptor Mth2-like, transcript variant X1
G-protein coupled receptor Mth2-like, transcript variant X2
uncharacterized protein LOC123503143 isoform X1
ATP-binding cassette sub-family D member 2-like
LOW QUALITY PROTEIN: ATP-binding cassette sub-family D member 2-like
DNA methyltransferase 1-associated protein 1-like
m7GpppN-mRNA hydrolase-like, transcript variant X1
m7GpppN-mRNA hydrolase-like, transcript variant X3
m7GpppN-mRNA hydrolase-like, transcript variant X2
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
WAS/WASL-interacting protein family member 1-like, transcript variant X7
WAS/WASL-interacting protein family member 1-like, transcript variant X5
WAS/WASL-interacting protein family member 1-like, transcript variant X1
WAS/WASL-interacting protein family member 1-like, transcript variant X4
WAS/WASL-interacting protein family member 1-like, transcript variant X2
WAS/WASL-interacting protein family member 1-like, transcript variant X3
WAS/WASL-interacting protein family member 1-like isoform X4
WAS/WASL-interacting protein family member 1-like isoform X2
WAS/WASL-interacting protein family member 1-like isoform X1
WAS/WASL-interacting protein family member 1-like, transcript variant X6
WAS/WASL-interacting protein family member 1-like isoform X3
26S proteasome non-ATPase regulatory subunit 1-like, transcript variant X2
26S proteasome non-ATPase regulatory subunit 1-like, transcript variant X1
26S proteasome non-ATPase regulatory subunit 1-like, transcript variant X3
26S proteasome non-ATPase regulatory subunit 1-like isoform X2
26S proteasome non-ATPase regulatory subunit 1-like isoform X1
26S proteasome non-ATPase regulatory subunit 1-like isoform X3
mitochondrial transcription rescue factor 1-like
carbohydrate sulfotransferase 11-like, transcript variant X1
carbohydrate sulfotransferase 8-like isoform X1
carbohydrate sulfotransferase 11-like, transcript variant X2
carbohydrate sulfotransferase 11-like, transcript variant X3
carbohydrate sulfotransferase 11-like isoform X2
carbohydrate sulfotransferase 11-like isoform X3
uncharacterized LOC123503164, transcript variant X1
uncharacterized LOC123503164, transcript variant X3
uncharacterized LOC123503164, transcript variant X2
long-chain specific acyl-CoA dehydrogenase, mitochondrial-like
KAT8 regulatory NSL complex subunit 1-like, transcript variant X1
KAT8 regulatory NSL complex subunit 1-like, transcript variant X4
KAT8 regulatory NSL complex subunit 1-like, transcript variant X3
KAT8 regulatory NSL complex subunit 1-like, transcript variant X2
KAT8 regulatory NSL complex subunit 1-like isoform X1
KAT8 regulatory NSL complex subunit 1-like isoform X3
KAT8 regulatory NSL complex subunit 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
xanthine dehydrogenase-like, transcript variant X5
xanthine dehydrogenase-like, transcript variant X6
xanthine dehydrogenase-like, transcript variant X3
xanthine dehydrogenase-like, transcript variant X1
xanthine dehydrogenase-like, transcript variant X2
xanthine dehydrogenase-like, transcript variant X4
NADH-cytochrome b5 reductase-like, transcript variant X2
NADH-cytochrome b5 reductase-like, transcript variant X1
leucine-rich repeat and coiled-coil domain-containing protein PF07_0014-like
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
general transcription factor 3C polypeptide 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: general transcription factor 3C polypeptide 1-like
transcription factor GATA-4-like, transcript variant X2
transcription factor GATA-4-like, transcript variant X1
transcription factor GATA-4-like, transcript variant X3
transcription factor GATA-4-like isoform X2
transcription factor GATA-4-like isoform X1
GATA-binding factor 2-like, transcript variant X3
GATA-binding factor 2-like, transcript variant X5
GATA-binding factor 2-like, transcript variant X2
GATA-binding factor 2-like, transcript variant X7
GATA-binding factor 2-like, transcript variant X1
GATA-binding factor 2-like, transcript variant X6
GATA-binding factor 2-like, transcript variant X4
GATA-binding factor 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
chitinase-like protein PB1E7.04c, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
chitinase-like protein PB1E7.04c, transcript variant X6
chitinase-like protein PB1E7.04c, transcript variant X4
chitinase-like protein PB1E7.04c, transcript variant X1
chitinase-like protein PB1E7.04c, transcript variant X7
chitinase-like protein PB1E7.04c, transcript variant X5
chitinase-like protein PB1E7.04c, transcript variant X2
chitinase-like protein PB1E7.04c isoform X3
nitrogen catabolic enzyme regulatory protein-like isoform X2
nitrogen catabolic enzyme regulatory protein-like isoform X1
uncharacterized LOC123503315, transcript variant X1
uncharacterized LOC123503315, transcript variant X2
uncharacterized LOC123503315, transcript variant X3
general transcription factor 3C polypeptide 5-like, transcript variant X3
general transcription factor 3C polypeptide 5-like, transcript variant X2
general transcription factor 3C polypeptide 5-like, transcript variant X1
general transcription factor 3C polypeptide 5-like isoform X2
general transcription factor 3C polypeptide 5-like isoform X1
LIM domain-containing protein A-like, transcript variant X2
LIM domain-containing protein A-like, transcript variant X1
LIM domain-containing protein A-like, transcript variant X3
LIM domain-containing protein A-like isoform X1
uncharacterized protein LOC123503322 isoform X2
uncharacterized protein LOC123503322 isoform X3
ubiquitin-conjugating enzyme E2 J1-like, transcript variant X2
ubiquitin-conjugating enzyme E2 J1-like isoform X2
ubiquitin-conjugating enzyme E2 J1-like, transcript variant X1
ubiquitin-conjugating enzyme E2 J1-like isoform X1
uncharacterized LOC123503326, transcript variant X3
uncharacterized LOC123503326, transcript variant X2
uncharacterized LOC123503326, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X4
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X6
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X5
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X3
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like
zinc finger SWIM domain-containing protein 7-like, transcript variant X1
zinc finger SWIM domain-containing protein 7-like, transcript variant X2
zinc finger SWIM domain-containing protein 7-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123503203
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
FAD-linked sulfhydryl oxidase ALR-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
FAD-linked sulfhydryl oxidase ALR-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
uncharacterized LOC123503166, transcript variant X1
uncharacterized LOC123503166, transcript variant X2
putative uncharacterized protein DDB_G0281733
cytosolic Fe-S cluster assembly factor nubp1-like
cell adhesion molecule 3-like, transcript variant X1
cell adhesion molecule 3-like isoform X1
cell adhesion molecule 3-like, transcript variant X2
cell adhesion molecule 3-like isoform X2
striatin-interacting protein 1 homolog, transcript variant X1
striatin-interacting protein 1 homolog, transcript variant X2
striatin-interacting protein 1 homolog isoform X1
striatin-interacting protein 1 homolog isoform X2
flavin-containing monooxygenase FMO GS-OX-like 4, transcript variant X1
flavin-containing monooxygenase FMO GS-OX-like 4, transcript variant X2
flavin-containing monooxygenase FMO GS-OX-like 4 isoform X1
flavin-containing monooxygenase FMO GS-OX-like 4 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
maltase-glucoamylase, intestinal-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
maltase-glucoamylase, intestinal-like, transcript variant X3
uncharacterized protein LOC123503251 isoform X2
maltase-glucoamylase, intestinal-like, transcript variant X1
maltase-glucoamylase, intestinal-like isoform X1